Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
Measles Cases in the US Increased Significantly in 2024
A recent spike in measles cases has threatened the elimination status of the disease in the US, prompting the CDC to continue vaccination initiatives across the country.
Measles rash on shoulder / weerapat1003 – stock.adobe.com
A 2019 outbreak in the northeastern part of the country has led to an alarming uptick in the number of cases, with 29% of cases from 2020 until now occurring in the first quarter of 2024.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
The phase 3 MONET trial (NCT05842967) includes 2 sub-studies that evaluated safety, tolerability, and immunogenicity of Abrysvo in adults at higher risk for RSV-associated disease.
MONET study participants achieved “at least a 4-fold increase in serum neutralizing titers for RSV-A and RSV-B” in the 1 month period after Abrysvo administration compared with pre-vaccination.
Buyer Beware: Red Yeast Rice Supplements Linked to Deaths, Hospitalizations
Japan’s health ministry has issued a warning to consumers regarding red yeast rice dietary supplements containing a red species of mold after 5 people died and more were hospitalized after consumption.
While no US products have been recalled yet, consumers everywhere should be cautious of supplements containing beni koji.
How Pharmacies Can Successfully Leverage 340B
At the American Associated Pharmacies annual conference, Eric Fromhart, co-founder and chief growth officer at Aventi Health, discussed how pharmacies can use 340B to increase profits and how they can avoid any potential risks when participating in the program.
According to Fromhart, pharmacists should be proactive in educating themselves about how 340B could be beneficial to their business.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
The FDA has approved benralizumab (Fasenra) as an add-on maintenance treatment for pediatric patients aged 6 to 11 years with severe asthma, with an eosinophilic phenotype.
The medication, manufactured by AstraZeneca, first received approval in 2017 as an add-on maintenance therapy for severe eosinophilic asthma in patients aged 12 years and older.
The Psychedelic Pharmacy: A Paradigm Shift in Mental Health Treatment
After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Rx Roundup: Quiz of the Week — April 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
Keeping Pharmacies Independent: Best Practices For Selling, Buying a Business
At AAP 2024, the Cardinal Health Pharmacy Transitions Services team hosted a session outlining how best to go about selling and buying a pharmacy.
The Psychedelic Pharmacy: A Paradigm Shift in Mental Health Treatment
After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Rx Roundup: Quiz of the Week — April 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
Keeping Pharmacies Independent: Best Practices For Selling, Buying a Business
At AAP 2024, the Cardinal Health Pharmacy Transitions Services team hosted a session outlining how best to go about selling and buying a pharmacy.
2 Commerce Drive
Cranbury, NJ 08512
609-716-7777
